Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Patanjali seeks Rs...

    Patanjali seeks Rs 1000 cr fiscal loan for expansion

    Written by Geeta Sharma Sharma Published On 2016-06-22T15:38:50+05:30  |  Updated On 22 Jun 2016 3:38 PM IST
    Patanjali seeks Rs 1000 cr fiscal loan for expansion
    Mumbai: Patanjali, Baba Ramdev’s consumer based industrial enterprise for Ayurvedic consumer products, is looking for a fiscal loan of 1000 Crores for expansion.

    Patanjali has narrowed its business gap with FMCG majors like Dabur, Marico and Godrej Consumer, by doubling its sales to 5000 crores in the past year. It is presently also giving competition to Hindustan Lever and Colgate.

    The company has approached UCO Bank, Bank of Baroda and the State Bank of India, in an effort to launch new project. The Banks have not come back on loans to the company as yet.

    "Long term project loans with 5-10 years maturity should serve our purposes. Project financing will increase as we expand our presence nation-wide, extending product lines. We require this as we are now setting up more plants across the country," says company's Managing Director, Acharya Balkrishna as reported in ET

    Patanjali already has a loan facility, from both the SBI and the Punjab National bank. But this credit is not related to long term project loans. Banks of High stature like the ICICI Bank and the HDFC have also approached Patanjali.

    "So far, we have been taking short term loans to meet our working capital requirements," adds Balakrishna.

    Baba Ramdev’s Patanjali Ayurved Ltd is assigned a BWR AA-/A1+ rating by ratings agency Brickwork Ratings for its bank loans of Rs.320 crore from the SBI.

    This SBI loan to Patanjali is under two facilities—The first a fund-based cash credit of Rs.300 crore for long term. The second a non-fund based bank guarantee for short term, worth Rs.20 crore.

    Analysts at India Infoline Ltd have estimated the company’s sales to grow from Rs.2,000 crore in financial year 2015 to Rs.20,000 crore by fiscal 2020. Patanjali will expand its network and enter new categories and also gains double digit market share in 10 of the 25 categories, says a live mint report.
    Baba RamdevDaburFMCGPatanjali Ayurved Ltd
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok